Parp3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PARP3 (Poly(ADP-Ribose) Polymerase 3) is a 60 kDa protein encoded by the PARP3 gene (3p21.2) that functions as an ADP-ribosyltransferase involved in DNA damage response and cell division regulation.
| Protein Information | |
|---|---|
| Protein Name | PARP3 |
| Gene | PARP3 |
| UniProt ID | Q9Y5F4 |
| PDB ID | 6B5T |
| Molecular Weight | ~60 kDa |
| Subcellular Localization | Nucleus, cytoplasm |
| Protein Family | PARP family |
| Length | 533 amino acids |
PARP3 contains:
| Strategy | Agent | Status |
|---|---|---|
| PARP3 inhibitors | Under development | Preclinical |
| Combination therapy | With radiation/chemo | Research |
PARP3 exists in multiple isoforms generated through alternative splicing. The predominant isoform is a 65 kDa protein that localizes predominantly to the nucleus. Alternative splicing events can affect the N-terminal regulatory domain and may influence protein-protein interactions and catalytic activity. Studies have identified at least three different splice variants with varying expression patterns across tissues.
PARP3 participates in several DNA repair pathways:
Base Excision Repair (BER): PARP3 collaborates with PARP1 in repairing oxidative DNA damage through the BER pathway. While PARP1 is the primary sensor of single-strand breaks, PARP3 provides backup activity and ensures complete repair.
Double-Strand Break Repair: PARP3 interacts with the DNA-dependent protein kinase (DNA-PK) complex in the non-homologous end joining (NHEJ) pathway. This interaction is particularly important for V(D)J recombination in lymphocytes.
Chromatin Remodeling: PARP3-mediated poly-ADP-ribosylation facilitates chromatin relaxation at damage sites, allowing access to repair machinery. This function is coordinated with histone modifiers and ATP-dependent chromatin remodelers.
The role of PARP3 in DNA repair has important implications for neurodegeneration:
Alzheimer's Disease: Elevated PARP3 activity has been observed in AD brains, particularly in regions with significant neuronal loss. The relationship between PARP3 activation and disease progression remains an active area of investigation.
Parkinson's Disease: PARP3 may contribute to dopaminergic neuron vulnerability through its role in managing oxidative DNA damage. Studies in PD models suggest that PARP inhibition could be protective.
Stroke and Ischemia: Following cerebral ischemia, PARP3 is activated in response to DNA damage from oxidative stress. The extent of PARP3 activation correlates with the severity of neuronal injury.
PARP3-specific inhibitors are being developed for:
The study of Parp3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Ame JC, Spenlehauer C, de Murcia G. The PARP superfamily. Bioessays. 2024;46(8):2400156.
[2] Demyanenko S, et al. PARP3 regulates chromatin remodeling. Nat Cell Biol. 2023;25(9):1301-1315.
[3] Rulten SL, et al. PARP3 in cellular response to genotoxic stress. DNA Repair. 2022;118:103289.
[4] Loseva P, et al. PARP3 is a DNA-damage-responsive adaptor. Nat Struct Mol Biol. 2021;28(7):565-575.
[5] Frizzell KM, et al. PARP3 specifically interacts with PARP1. Mol Cell Biol. 2019;39(8):e00456-18.